首页> 外国专利> METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND UDENAFIL

METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND UDENAFIL

机译:辛伐他汀与乌地那非联合应用对实验性骨骼肌缺血的药理校正方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, particularly to experimental pharmacology and surgery. Method of pharmacological correction of experimental ischemia of skeletal muscle with a combination of simvastatin and udenafil involves experimental modeling of critical ischemia of shin muscles, where simvastatin is administered intragastrically in dose of 0.86 mg/kg and udenafil is administered intragastrically in dose of 0.86 mg/kg once a day daily for 14 days.;EFFECT: invention can be used to simulate critical skeletal muscle ischemia.;1 cl, 1 tbl, 1 ex
机译:技术领域本发明涉及医学,尤其涉及实验药理学和外科手术。辛伐他汀和udenafil组合对骨骼肌实验性缺血的药理校正方法涉及胫骨肌肉严重缺血的实验模型,其中辛伐他汀以0.86 mg / kg的剂量在胃内给药,而乌地那非以0.86 mg / kg的剂量在胃内给药每天一次,每天一次,每公斤kg,共14天。;效果:本发明可用于模拟严重的骨骼肌缺血。1cl,1 tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号